Alliance A031501 - Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) versus Observation

Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) versus Observation. https://www.clinicaltrials.gov/ct2/show/NCT03244384

Alliance A031501
Cancer
Maria Sbenghe, MD
Enrolling
Blair Thomas, RN BSN
(585) 747-4555